• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非典型玻璃化转变和无定形普萘洛尔盐的重结晶行为研究。

Investigation of the atypical glass transition and recrystallization behavior of amorphous prazosin salts.

机构信息

Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar, Mohali, Punjab-160 062, India.

出版信息

Pharmaceutics. 2011 Aug 25;3(3):525-37. doi: 10.3390/pharmaceutics3030525.

DOI:10.3390/pharmaceutics3030525
PMID:24310595
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3857081/
Abstract

This manuscript studied the effect of counterion on the glass transition and recrystallization behavior of amorphous salts of prazosin. Three amorphous salts of prazosin, namely, prazosin hydrochloride, prazosin mesylate and prazosin tosylate were prepared by spray drying, and characterized by optical-polarized microscopy, differential scanning calorimetry and powder X-ray diffraction. Modulated differential scanning calorimetry was used to determine the glass transition and recrystallization temperature of amorphous salts. Glass transition of amorphous salts followed the order: prazosin mesylate > prazosin tosylate ~ prazosin hydrochloride. Amorphous prazosin mesylate and prazosin tosylate showed glass transition, followed by recrystallization. In contrast, amorphous prazosin hydrochloride showed glass transition and recrystallization simultaneously. Density Functional Theory, however, suggested the expected order of glass transition as prazosin hydrochloride > prazosin mesylate > prazosin tosylate. The counterintuitive observation of amorphous prazosin hydrochloride having lower glass transition was explained in terms of its lower activation energy (206.1 kJ/mol) for molecular mobility at Tg, compared to that for amorphous prazosin mesylate (448.5 kJ/mol) and prazosin tosylate (490.7 kJ/mol), and was further correlated to a difference in hydrogen bonding strength of the amorphous and the corresponding recrystallized salts. This study has implications in selection of an optimal amorphous salt form for pharmaceutical development.

摘要

本文研究了抗衡离子对普萘洛尔无定形盐玻璃化转变和重结晶行为的影响。通过喷雾干燥法制备了普萘洛尔盐酸盐、普萘洛尔甲磺酸盐和普萘洛尔对甲苯磺酸盐三种普萘洛尔无定形盐,并通过偏光显微镜、差示扫描量热法和粉末 X 射线衍射进行了表征。采用调制差示扫描量热法测定了无定形盐的玻璃化转变和重结晶温度。无定形盐的玻璃化转变顺序为:普萘洛尔甲磺酸盐>普萘洛尔对甲苯磺酸盐~普萘洛尔盐酸盐。无定形普萘洛尔甲磺酸盐和普萘洛尔对甲苯磺酸盐先发生玻璃化转变,然后发生重结晶。相比之下,无定形普萘洛尔盐酸盐则同时发生玻璃化转变和重结晶。然而,密度泛函理论预测的玻璃化转变顺序为普萘洛尔盐酸盐>普萘洛尔甲磺酸盐>普萘洛尔对甲苯磺酸盐。无定形普萘洛尔盐酸盐的玻璃化转变较低,这一反直觉的观察结果可以用其在 Tg 时分子迁移的较低活化能(206.1 kJ/mol)来解释,而无定形普萘洛尔甲磺酸盐(448.5 kJ/mol)和普萘洛尔对甲苯磺酸盐(490.7 kJ/mol)则较高,这与无定形盐和相应的重结晶盐的氢键强度差异有关。本研究对选择最佳的无定形盐形式用于药物开发具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f56c/3857081/432c5b32af7b/pharmaceutics-03-00525f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f56c/3857081/cf3f78047ec8/pharmaceutics-03-00525f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f56c/3857081/2f505c89df13/pharmaceutics-03-00525f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f56c/3857081/96832d410dcb/pharmaceutics-03-00525f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f56c/3857081/eae4ee1e9b92/pharmaceutics-03-00525f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f56c/3857081/a3192146ecea/pharmaceutics-03-00525f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f56c/3857081/432c5b32af7b/pharmaceutics-03-00525f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f56c/3857081/cf3f78047ec8/pharmaceutics-03-00525f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f56c/3857081/2f505c89df13/pharmaceutics-03-00525f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f56c/3857081/96832d410dcb/pharmaceutics-03-00525f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f56c/3857081/eae4ee1e9b92/pharmaceutics-03-00525f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f56c/3857081/a3192146ecea/pharmaceutics-03-00525f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f56c/3857081/432c5b32af7b/pharmaceutics-03-00525f6.jpg

相似文献

1
Investigation of the atypical glass transition and recrystallization behavior of amorphous prazosin salts.非典型玻璃化转变和无定形普萘洛尔盐的重结晶行为研究。
Pharmaceutics. 2011 Aug 25;3(3):525-37. doi: 10.3390/pharmaceutics3030525.
2
Effect of counterions on physicochemical properties of prazosin salts.反离子对特拉唑嗪盐理化性质的影响。
AAPS PharmSciTech. 2013 Mar;14(1):141-50. doi: 10.1208/s12249-012-9889-x. Epub 2012 Dec 19.
3
Effect of counterion on the solid state photodegradation behavior of prazosin salts.反离子对普萘洛尔盐固态光降解行为的影响。
AAPS PharmSciTech. 2013 Jun;14(2):757-63. doi: 10.1208/s12249-013-9961-1. Epub 2013 Apr 18.
4
Effect of counterions on the properties of amorphous atorvastatin salts.抗衡离子对阿托伐他汀无定形盐性质的影响。
Eur J Pharm Sci. 2011 Nov 20;44(4):462-70. doi: 10.1016/j.ejps.2011.08.023. Epub 2011 Sep 1.
5
Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.喷雾干燥共无定形药物 - 氨基酸盐的制备与表征
J Pharm Pharmacol. 2016 May;68(5):615-24. doi: 10.1111/jphp.12458. Epub 2015 Aug 5.
6
Effect of a counterion on the glass transition temperature (T(g)') during lyophilization of ganciclovir salt forms.甘昔洛韦盐形式冷冻干燥过程中抗衡离子对玻璃化转变温度(T(g) ')的影响。
Mol Pharm. 2011 Feb 7;8(1):309-14. doi: 10.1021/mp100357t. Epub 2010 Dec 20.
7
[Investigation of the recrystallization of trehalose as a good glass-former excipient].[海藻糖作为优良玻璃形成剂辅料的重结晶研究]
Acta Pharm Hung. 2014;84(1):7-14.
8
An investigation into the influence of counterion on the properties of some amorphous organic salts.抗衡离子对某些无定形有机盐性质影响的研究。
Mol Pharm. 2008 Nov-Dec;5(6):946-55. doi: 10.1021/mp8000342.
9
Inhibition of Recrystallization of Amorphous Lactose in Nanocomposites Formed by Spray-Drying.喷雾干燥形成的纳米复合材料中无定形乳糖再结晶的抑制作用
J Pharm Sci. 2015 Nov;104(11):3760-3769. doi: 10.1002/jps.24583. Epub 2015 Jul 16.
10
Different or the same? exploring the physicochemical properties and molecular mobility of celecoxib amorphous forms.不同还是相同?探索塞来昔布无定形形式的物理化学性质和分子迁移率。
Int J Pharm. 2024 Aug 15;661:124470. doi: 10.1016/j.ijpharm.2024.124470. Epub 2024 Jul 14.

引用本文的文献

1
Technological Application of Maltodextrins According to the Degree of Polymerization.根据聚合度对麦芽糊精的技术应用
Molecules. 2015 Nov 27;20(12):21067-81. doi: 10.3390/molecules201219746.
2
Prazosin-Conjugated Matrices Based on Biodegradable Polymers and α-Amino Acids--Synthesis, Characterization, and in Vitro Release Study.基于可生物降解聚合物和α-氨基酸的哌唑嗪共轭基质——合成、表征及体外释放研究
Molecules. 2015 Aug 12;20(8):14533-51. doi: 10.3390/molecules200814533.

本文引用的文献

1
Density-functional theory of the electronic structure of molecules.分子电子结构的密度泛函理论。
Annu Rev Phys Chem. 1995;46:701-28. doi: 10.1146/annurev.pc.46.100195.003413.
2
Analysis of relationships between solid-state properties, counterion, and developability of pharmaceutical salts.分析固态性质、反离子与药物盐可开发性之间的关系。
AAPS PharmSciTech. 2010 Sep;11(3):1212-22. doi: 10.1208/s12249-010-9499-4. Epub 2010 Aug 3.
3
An investigation into the influence of counterion on the properties of some amorphous organic salts.
抗衡离子对某些无定形有机盐性质影响的研究。
Mol Pharm. 2008 Nov-Dec;5(6):946-55. doi: 10.1021/mp8000342.
4
Role of thermodynamic, molecular, and kinetic factors in crystallization from the amorphous state.热力学、分子和动力学因素在非晶态结晶中的作用。
J Pharm Sci. 2008 Apr;97(4):1329-49. doi: 10.1002/jps.21138.
5
Solubility: it's not just for physical chemists.溶解度:它不仅仅关乎物理化学家。
Drug Discov Today. 2006 Nov;11(21-22):1012-8. doi: 10.1016/j.drudis.2006.09.002. Epub 2006 Sep 26.
6
A comparison of the physical stability of amorphous felodipine and nifedipine systems.非晶态非洛地平和硝苯地平体系的物理稳定性比较。
Pharm Res. 2006 Oct;23(10):2306-16. doi: 10.1007/s11095-006-9047-9. Epub 2006 Aug 23.
7
Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine.不同聚合物对分子分散无定形非洛地平结晶倾向的影响。
J Pharm Sci. 2006 Dec;95(12):2692-705. doi: 10.1002/jps.20697.
8
Structural relaxation of acetaminophen glass.对乙酰氨基酚玻璃的结构弛豫
Pharm Res. 2006 May;23(5):967-79. doi: 10.1007/s11095-006-9898-0. Epub 2006 May 16.
9
Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.盐酸哌唑嗪与β-环糊精和羟丙基-β-环糊精包合物的制备与表征
J Pharm Biomed Anal. 2006 Jan 23;40(1):122-7. doi: 10.1016/j.jpba.2005.06.022. Epub 2005 Aug 10.
10
Structural characterization of prazosin hydrochloride and prazosin free base.盐酸哌唑嗪和哌唑嗪游离碱的结构表征。
J Pharm Sci. 2004 Dec;93(12):3090-5. doi: 10.1002/jps.20204.